|
|
 |
|
Viewing report
|
|
|
Anthera Pharmaceuticals Inc (07-Feb-2012)
Directors Deals Ltd, Feb 2012, Pages: 1
Colin Hislop, (PDMR) Chief Medical Officer of Anthera Pharmaceuticals Inc [market cap £213million] sold 30,000 shares at 8.200USD, holding is now 43,150 shares; representing 0.105 percent of the shares on issue. Holding has decreased 41 percent, the total trade value was £155,382 and the significance rating is 58/100.
Directors Deals monitors and analyses share transactions made by directors in the shares of their own company. We monitor 18,000 companies share transactions in 46 countries worldwide (32 in Europe, 7 in Asia, 2 in North America, 2 in Oceania, 2 in the Middle East & 2 in Africa).
|
|
|
|
